참고문헌
- Burrow TA, Hopkin RJ, Leslie ND, Tinkle BT, Grabowski GA. Enzymereconstitution/replacement therapy fo rlysosomal storage disease. Current Opinion in Pediatrics 2007;19:628-35. https://doi.org/10.1097/MOP.0b013e3282f161f2
- Neufeld EF MJ. The mucopolysaccharidoses. In: Scriver CR, BeaudetAL, Sly WS, et al., editors. The metabolic and molecular bases of inherited disease. 8th Ed. New York: McGraw-Hill; 2001;3421-52.
- Martin R, Beck M, Eng C, Giugliani R, Harmatz P, Munoz V, et al. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome). Pediatrics 2008;121:e377-86. https://doi.org/10.1542/peds.2007-1350
- Beebe RT, Formel PF. Gargoylism: sex-linked transmission in nine males. Trans Am Clin Climatol Assoc 1955;66:199-207.
- Hunter C. A rare disease in two brothers. Proc R Soc Med. 1917;10:104-16.
- Lin HY, Lin SP, Chuang CK, Niu DM, Chen MR, Tsai FJ, et al. Incidence of the mucopolysaccharidosis in Taiwan, 1984-2004. Am J Med Genet A 2009;149A:960-4. https://doi.org/10.1002/ajmg.a.32781
- Cho SY, Jin DK. Distribution of Patients with Mucopolysaccharidosis in East Asia and Current Status and Prospect for Treatment. J Korean Soc Inherit Metab Dis 2013;13:81-8.
- Noh H, Lee JI. Current and potential therapeutic strategies for mucopolysaccharide. J Clin Pharm Ther 2014;39:215-24. https://doi.org/10.1111/jcpt.12136
- Young ID, Harper PS. Mild form of Hunter's syndrome: clinical delineation based on 31 cases. Arch Dis Child 1982;57:828-36. https://doi.org/10.1136/adc.57.11.828
- Burton BK, Giugliani R. Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls. Eur J Pediatr 2012;171:631-9. https://doi.org/10.1007/s00431-012-1703-y
- Sohn YB, Cho SY, Park SW, et al. Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter syndrome). Orphanet J Rare Dis 2013;8:42. https://doi.org/10.1186/1750-1172-8-42
- Muenzer J. Early initiation of enzyme replacement therapy for the mucopolysaccharidosis. Mol Genet Metab 201;111:63-72. https://doi.org/10.1016/j.ymgme.2013.11.015
- Giugliani R, Hwu WL, Tylki-Szymanska A, Whiterman DA, Pano A. A multicenter, open-label study evaluation safety and clinical outcomes in children (1.4-7.5 years) with Hunter syndrome receiving idursulfase enzyme replacement therapy. Genet Med 2014;16:435-41. https://doi.org/10.1038/gim.2013.162
- Wraith JE, Beck M, Giugliani R, Clarke J, Martin R, Muenzer J. Initial report from the Hunter Outcome Survey. Genet Med. 2008;10:508-16. https://doi.org/10.1097/GIM.0b013e31817701e6
- Park SW, Sohn YB, Kim SH, et al. Enzyme replacement therapy in patients who have mucopolysaccharidosis and are younger than 5 years old. J Korean Soc Inherit Metab Dis 2010;10:59-66.